
61.62 Delayed Data As of Aug 08 | ![]() Today’s Change | 57.17 Today|||52-Week Range 74.12 | -15.14% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $76.6B |
Gilead Sciences, Inc. 333 Lakeside Drive Foster City California 94404 |
Daniel P. O'Day | Chairman & Chief Executive Officer |
Andrew D. Dickinson | Chief Financial Officer |
Merdad V. Parsey | Chief Medical Officer |
Flavius Martin | Executive Vice President-Research |
Diane E. Wilfong | Chief Accounting Officer & Senior Vice President |